Theratechnologies INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$3.0Mgeneral payments (2019-2025)
$225Kresearch payments (2019-2025)
4,303clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Mace Rothenberg | Nashville, TN | Medical Oncology | $301,995.67 |
| Robin Beach | Houston, TX | Family | $244,722.59 |
| Jihad Slim | Newark, NJ | Infectious Disease | $149,316.49 |
| Claudia Martorell | Springfield, MA | Infectious Disease | $130,466.56 |
| Brian Beesley | Columbus, OH | Family Medicine | $92,377.79 |
| Elizabeth Race | Dallas, TX | Infectious Disease | $90,250.84 |
| Jason Leider | Bronx, NY | Internal Medicine | $74,197.41 |
| Rohit Loomba | La Jolla, CA | Internal Medicine | $68,180.55 |
| Fred Sattler | Los Angeles, CA | Infectious Disease | $62,531.01 |
| Ronald Ellis | San Diego, CA | Neurology (Psychiatry & Neurology) | $62,500.46 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.